--- title: Drug Prices Drop, Pharma Faces a New Game description: Trump’s Most-Favored-Nation drug pricing deal with Pfizer cuts U.S. drug costs, reshapes industry profits, and creates winners and losers among American pharmaceutical firms image: https://resources.quantel.ai/hubfs/iStock-1213235764.jpg --- [![quantel_mainlogo](https://resources.quantel.ai/hubfs/quantel_mainlogo.png)](https://www.quantel.ai/) - [For Investors](https://www.quantel.ai/investors/) - [For RIAs](https://www.quantel.ai/rias/) - [Resources](https://www.quantel.ai/resources/) - [About](https://www.quantel.ai/about/) [Get Started Today](https://myaccount.quantel.ai/) [Get Started Today](https://myaccount.quantel.ai/) false # Drug Prices Drop, Pharma Faces a New Game [BACK](https://resources.quantel.ai/) By   Jerry Yuan Oct 4, 2025, 5:59:59 AM | 3 mins [![](https://resources.quantel.ai/hubfs/Social_Icons/linkcopy_icon.svg)](https://resources.quantel.ai/?rel=author) President Trump’s MFN drug pricing deal with Pfizer marks a historic shift in U.S. pharmaceutical policy by linking prices to international benchmarks and driving significant discounts for patients. Markets responded positively as the cooperative approach reduced policy uncertainty. However, the deal disrupts the industry’s profit model, forcing companies to adapt to lower pricing power and new political pressures. Investors now face a landscape where strong R&D pipelines and manufacturing capacity will determine long-term winners and losers.   #### A Landmark Shift in U.S. Pharmaceutical Pricing Policy President Trump’s Most-Favored-Nation (MFN) drug pricing agreement with Pfizer represents one of the most significant shifts in U.S. pharmaceutical policy in decades. Under this deal, drug prices in the U.S. will be tied to the lowest prices in other developed nations, effectively ending the long-standing system where Americans shouldered disproportionately higher costs. Pfizer agreed to provide discounts of up to 85% on specific products and committed to investing $70 billion in U.S. manufacturing in exchange for a three-year exemption from tariffs. For patients, the policy delivers immediate relief: medicines such as Eucrisa, Xeljanz, and Zavzpret will see discounts ranging from 40% to 80%, lowering costs for millions of Americans covered under Medicaid or purchasing directly through future government platforms like TrumpRx.gov.   #### Markets Cheer Cooperative Policy Approach The market response to the announcement was unexpectedly positive. Shares of major U.S. pharmaceutical firms, including Pfizer, Eli Lilly, Merck, AbbVie, and Bristol Myers Squibb, rose between 2% and 7% following the news. Investors had long feared an abrupt, punitive approach from the Trump administration—such as sweeping tariffs or unilateral caps without negotiation. Instead, the Pfizer deal signaled a more cooperative path, giving companies time to adjust while providing clarity on the rules of engagement. This outcome reduced uncertainty, a factor that had weighed on valuations for years. In the short term, the sector has benefited from what many analysts see as the removal of a policy overhang.   #### Disrupting a Profitable Status Quo Yet beneath the relief rally lies a more challenging long-term reality. For years, U.S. drugmakers relied on charging far higher prices domestically to compensate for heavy discounts abroad, with America accounting for roughly three-quarters of global pharmaceutical profits despite making up less than 5% of the world’s population. The MFN framework disrupts this model. By compressing U.S. pricing power, the policy is likely to slow revenue and margin growth across the sector. Companies with deep pipelines and strong R&D output, such as Eli Lilly, are better positioned to offset this pressure by developing new blockbuster drugs. In contrast, firms like AbbVie and Bristol-Myers, which face looming patent expirations and rely heavily on U.S. revenue streams, may find it more challenging to adapt to these changes.   #### Political Pressure Forces Industry Recalibration The political backdrop further underscores the significance of the stakes. President Trump has indicated that Pfizer’s deal is the first of many, with other major drugmakers expected to sign similar agreements. Those unwilling to comply face the threat of a 100% tariff on branded pharmaceutical products unless they commit to building U.S. manufacturing facilities. This creates a high-pressure environment where companies must either sacrifice near-term profitability through price cuts or risk losing critical access to the American market. In effect, the policy forces a recalibration of business models across the industry.   #### Winners and Losers Emerge in a Diverging Sector For investors, the sector is entering a period of heightened divergence. The winners will be large-cap firms with the resources to scale U.S. production, invest in innovation, and absorb thinner margins while continuing to grow earnings. Pfizer, by moving first, secured goodwill from the administration and removed uncertainty for its shareholders. The losers will be smaller or less diversified companies that cannot reinvest profits into new drugs or shift supply chains effectively. Biotechs dependent on premium U.S. pricing for funding innovation could be particularly vulnerable, as compressed margins make it harder to justify high development costs.   #### A New Era for Drug Pricing and Investment Strategy The MFN initiative delivers tangible benefits to patients and removes near-term uncertainty for investors, which explains the sector’s positive reaction. However, the longer-term landscape is one of structural change. The era of outsized U.S. profits is coming to an end, giving way to a model that prioritizes affordability and domestic production. For equity investors, this means distinguishing between companies that can adapt and innovate and those that will struggle under tighter pricing constraints. Pfizer’s first-mover advantage positions it favorably, but as similar deals extend to peers, the entire sector must navigate a new normal where pricing power is no longer a given, and long-term performance will hinge on operational agility, R&D strength, and political alignment. ### EXPLORE MORE POSTS [![Macro Risk and Market Rotation: What It Means for Equities, Gold and Crypto](https://resources.quantel.ai/hubfs/iStock-2182976025.jpg)](https://resources.quantel.ai/macro-risk-and-market-rotation-what-it-means-for-equities-gold-and-crypto) #### Macro Risk and Market Rotation: What It Means for Equities, Gold and Crypto Markets are facing a renewed shift in leadership as Federal Reserve policy [Read More](https://resources.quantel.ai/macro-risk-and-market-rotation-what-it-means-for-equities-gold-and-crypto) ###### by Jerry Yuan August 29, 2026 [![What Do Institutional Investors Do Differently With Risk?](https://resources.quantel.ai/hubfs/iStock-2284161603.jpg)](https://resources.quantel.ai/what-do-institutional-investors-do-differently-with-risk) #### What Do Institutional Investors Do Differently With Risk? When markets are rising, risk management can feel secondary. When volatility... [Read More](https://resources.quantel.ai/what-do-institutional-investors-do-differently-with-risk) ###### by Irman Singh August 26, 2026 [![Rising Treasury Yields Reshape Markets](https://resources.quantel.ai/hubfs/iStock-1134157197.jpg)](https://resources.quantel.ai/rising-treasury-yields-reshape-markets) #### Rising Treasury Yields Reshape Markets Rising Treasury yields are reshaping markets, putting pressure on equity... [Read More](https://resources.quantel.ai/rising-treasury-yields-reshape-markets) ###### by Jerry Yuan August 22, 2026 [![AI vs. Manual Portfolio Monitoring](https://resources.quantel.ai/hubfs/iStock-1513403586.jpg)](https://resources.quantel.ai/ai-vs.-manual-portfolio-monitoring) #### AI vs. Manual Portfolio Monitoring Portfolio monitoring has traditionally relied on human attention: reviewing... [Read More](https://resources.quantel.ai/ai-vs.-manual-portfolio-monitoring) ###### by Irman Singh August 19, 2026 [![Inflation cools as AI infrastructure and memory rebound](https://resources.quantel.ai/hubfs/Untitled%20Design%20(6).png)](https://resources.quantel.ai/inflation-cools-as-ai-infrastructure-and-memory-rebound) #### Inflation cools as AI infrastructure and memory rebound Markets closed the week higher as cooling inflation offset early jitters over... [Read More](https://resources.quantel.ai/inflation-cools-as-ai-infrastructure-and-memory-rebound) ###### by Jerry Yuan August 16, 2026 [![Why HNI's Should Think Like Endowments: A Smarter Approach to Long-Term Wealth Management](https://resources.quantel.ai/hubfs/iStock-2214686899.jpg)](https://resources.quantel.ai/why-hnis-should-think-like-endowments-a-smarter-approach-to-long-term-wealth-management) #### Why HNI's Should Think Like Endowments: A Smarter Approach to Long-Term Wealth Management High-net-worth individuals (HNIs) often have something that many institutional... [Read More](https://resources.quantel.ai/why-hnis-should-think-like-endowments-a-smarter-approach-to-long-term-wealth-management) ###### by Irman Singh August 12, 2026 [![From AI Spending to AI Earnings](https://resources.quantel.ai/hubfs/iStock-2236346525.jpg)](https://resources.quantel.ai/from-ai-spending-to-ai-earnings) #### From AI Spending to AI Earnings The market’s message this week was constructive. Major indexes rebounded as... [Read More](https://resources.quantel.ai/from-ai-spending-to-ai-earnings) ###### by Jerry Yuan August 8, 2026 [![Ten Features Every Modern Wealth Platform Needs](https://resources.quantel.ai/hubfs/iStock-1496158297.jpg)](https://resources.quantel.ai/ten-features-every-modern-wealth-platform-needs) #### Ten Features Every Modern Wealth Platform Needs **The Era of Passive Wealth Management Is Changing** Investing has become more... [Read More](https://resources.quantel.ai/ten-features-every-modern-wealth-platform-needs) ###### by Irman Singh August 5, 2026 [![AI Demand Remains Strong Despite Market Volatility](https://resources.quantel.ai/hubfs/iStock-1693427536.jpg)](https://resources.quantel.ai/ai-demand-remains-strong-despite-market-volatility) #### AI Demand Remains Strong Despite Market Volatility AI/semiconductor stocks saw a sharp selloff and rebound this week, but earnings... [Read More](https://resources.quantel.ai/ai-demand-remains-strong-despite-market-volatility) ###### by Jerry Yuan August 1, 2026 [![What Is Agentic AI in Wealth Management?](https://resources.quantel.ai/hubfs/iStock-2281698394.jpg)](https://resources.quantel.ai/what-is-agentic-ai-in-wealth-management) #### What Is Agentic AI in Wealth Management? Every few years, a new category of technology arrives that doesn't just improve... [Read More](https://resources.quantel.ai/what-is-agentic-ai-in-wealth-management) ###### by Irman Singh July 29, 2026 [![The AI Trade Pauses as Investors Reassess AI CapEx Growth](https://resources.quantel.ai/hubfs/iStock-2207141986.jpg)](https://resources.quantel.ai/the-ai-trade-pauses-as-investors-reassess-ai-capex-growth) #### The AI Trade Pauses as Investors Reassess AI CapEx Growth The recent pullback in semiconductor stocks has shifted investor attention from... [Read More](https://resources.quantel.ai/the-ai-trade-pauses-as-investors-reassess-ai-capex-growth) ###### by Jerry Yuan July 25, 2026 [![The Hidden Risk of Calm Markets](https://resources.quantel.ai/hubfs/iStock-1187626203.jpg)](https://resources.quantel.ai/the-hidden-risk-of-calm-markets) #### The Hidden Risk of Calm Markets Investors naturally pay more attention when markets become volatile. Headlines... [Read More](https://resources.quantel.ai/the-hidden-risk-of-calm-markets) ###### by Irman Singh July 22, 2026 [![AI Stocks Pull Back, but the Long-Term AI Investment Story Remains Intact](https://resources.quantel.ai/hubfs/iStock-1490812495.jpg)](https://resources.quantel.ai/does-your-wealth-management-solution-actually-deliver) #### AI Stocks Pull Back, but the Long-Term AI Investment Story Remains Intact The AI trade paused this week as investors took profits in semiconductor and AI... [Read More](https://resources.quantel.ai/does-your-wealth-management-solution-actually-deliver) ###### by Jerry Yuan July 15, 2026 [![Semiconductors Pull Back, but Investor Demand Remains Strong](https://resources.quantel.ai/hubfs/iStock-2214693325.jpg)](https://resources.quantel.ai/semiconductors-pull-back-but-investor-demand-remains-strong) #### Semiconductors Pull Back, but Investor Demand Remains Strong Despite a sharp correction in semiconductor stocks, long-term confidence in the... [Read More](https://resources.quantel.ai/semiconductors-pull-back-but-investor-demand-remains-strong) ###### by Jerry Yuan July 11, 2026 [![Why Long-Term RIAs Outperform Short-Term Thinkers](https://resources.quantel.ai/hubfs/iStock-2234639448.jpg)](https://resources.quantel.ai/why-long-term-rias-outperform-short-term-thinkers) #### Why Long-Term RIAs Outperform Short-Term Thinkers Markets move by the minute. Headlines change by the hour. But wealth is built... [Read More](https://resources.quantel.ai/why-long-term-rias-outperform-short-term-thinkers) ###### by Irman Singh July 8, 2026 [![AI Infrastructure Faces a Technical Reset as Markets Reassess Capex Expectations](https://resources.quantel.ai/hubfs/iStock-2163547048.jpg)](https://resources.quantel.ai/ai-infrastructure-faces-a-technical-reset-as-markets-reassess-capex-expectations) #### AI Infrastructure Faces a Technical Reset as Markets Reassess Capex Expectations Following last week’s discussion around more selective AI leadership, this week... [Read More](https://resources.quantel.ai/ai-infrastructure-faces-a-technical-reset-as-markets-reassess-capex-expectations) ###### by Jerry Yuan July 4, 2026 [![The Hidden Tax Drags Quietly Eroding Your Wealth](https://resources.quantel.ai/hubfs/iStock-1575126038.jpg)](https://resources.quantel.ai/the-hidden-tax-drags-quietly-eroding-your-wealth) #### The Hidden Tax Drags Quietly Eroding Your Wealth For investors, the conversation about returns tends to center on asset... [Read More](https://resources.quantel.ai/the-hidden-tax-drags-quietly-eroding-your-wealth) ###### by Irman Singh July 1, 2026 [![AI Demand Remains Strong Despite Sector Rotation in U.S. Markets](https://resources.quantel.ai/hubfs/iStock-1512227617-1.jpg)](https://resources.quantel.ai/ai-demand-remains-strong-despite-sector-rotation-in-u.s.-markets) #### AI Demand Remains Strong Despite Sector Rotation in U.S. Markets Last week, we discussed how the market continued to climb despite macro... [Read More](https://resources.quantel.ai/ai-demand-remains-strong-despite-sector-rotation-in-u.s.-markets) ###### by Jerry Yuan June 27, 2026 ### GET ACCESS TO THIS ARTICLE Breaking stories, exclusive insights, and expert analysis—just one step away. Enter your email to read the full story By subscribing, you accept our  [Privacy Policy](https://www.quantel.ai/policies/privacy-policy)  and  [Terms of Service](https://www.quantel.ai/policies/terms-of-use) [Privacy](https://www.quantel.ai/privacy/)[Terms](https://www.quantel.ai/terms/)[Legal](https://www.quantel.ai/legal/) © 2026 Quantel. All rights reserved. #### Products - [Quantel AI](https://www.quantel.ai/investors/#quantel-ai) - [Quantel INSIGHTS](https://www.quantel.ai/quantel-insights/) - [Quantel INVEST](https://www.quantel.ai/quantel-invest/) - [Quantel ADVISE](https://www.quantel.ai/quantel-advise/) - [Quantel FAMILY OFFICE](https://www.quantel.ai/investors/#quantel-family-office) #### Explore - [For Investors](https://www.quantel.ai/investors/) - [For RIAs](https://www.quantel.ai/rias/) - [Company - About](https://www.quantel.ai/about/) - [Company - Resources](https://www.quantel.ai/resources/) #### Contact us - [contact@quantel.ai](mailto:contact@quantel.ai) 100 Park Avenue, New York, NY 10017 ### Legal disclosure Investment research, investment advisory, and investment management services are offered by Quantel Asset Management LLC (previously called Tenjin AI Capital Advisors, LLC), an SEC-registered investment advisor (CRD: 311013). Registration with the SEC does not imply a certain level of skill or training. By using this website, you accept our [Terms of Use](https://www.quantel.ai/terms/) and [Privacy Policy](https://www.quantel.ai/privacy/). Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities. Past performance is no guarantee of future results. Any historical returns, expected returns, or projections based on probability are hypothetical in nature and may not reflect actual future performance. Account holdings are for illustrative purposes only and are not investment recommendations. Information provided by Quantel Asset Management in our website, newsletter, blogs, brochures, emails, or in any format or by any of their staff is for informational and general educational purposes only and is not investment or financial advice. Nothing on our website or our correspondence should be considered an offer, solicitation of an offer, or advice to buy or sell securities or investment products. The content on our website is for informational purposes only and does not constitute a comprehensive description of Quantel Asset Management's services. Investment losses are possible, including the potential loss of all amounts invested. Brokerage services are provided to Quantel Asset Management's investment services clients by [Interactive Brokers](https://ibkr.com/) and [Charles Schwab](https://www.schwab.com), both SEC-registered broker-dealers and members of FINRA/SIPC. For more information, please see their disclosures on their respective websites. ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Jerry Yuan", "url" : "https://resources.quantel.ai/author/jerry-yuan" }, "dateModified" : "2025-10-04T09:59:59.844Z", "datePublished" : "2025-10-04T09:59:59.000Z", "headline" : "Drug Prices Drop, Pharma Faces a New Game", "image" : [ "https://resources.quantel.ai/hubfs/iStock-1213235764.jpg" ], "mainEntityOfPage" : { "@id" : "https://resources.quantel.ai/a-new-era-begins-for-american-pharma-under-mfn-pricing", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://resources.quantel.ai/hubfs/Light%20mode%20Logo+Text@4x-8.png" }, "name" : "QUANTEL AI" } } ```